Literature DB >> 30231956

A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review.

Jakko van Ingen1, Christine Y Turenne2, Enrico Tortoli3, Richard J Wallace4, Barbara A Brown-Elliott4.   

Abstract

Nontuberculous mycobacteria, particularly the Mycobacterium avium complex (MAC) bacteria, are increasingly recognized as opportunistic pathogens of humans. As a result, studies on antibiotic treatment and taxonomy of the MAC are intensifying, but an updated definition of what constitutes the MAC, either for taxonomical studies or for clinical purposes, is lacking. On the basis of literature review and phylogenetic analyses, we propose to define the MAC as a grouping of slow-growing mycobacteria that show corresponding values in at least two of the following targets against either M. avium ATCC 25291T or Mycobacterium intracellulare ATCC 13950T: >99.4 % sequence identity for the full 16S rRNA gene, >98.7 % for the partial (5') 16S rRNA gene, >97.3 % for hsp65 and >94.4 % for rpoB region V. A >97.5 % value in concatenated analyses of >2500 bp that includes 16S rRNA, hsp65 and rpoB gene sequence data or ≥85 % average nucleotide identity to M. avium ATCC 25291T or M. intracellulare ATCC 13950T on basis of whole genome sequencing data is recommended. This molecular definition is based on the distances observed between the classical members of the MAC, M. avium and M. intracellulare. Applying this definition, the complex currently consists of 12 validly published species: Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium chimaera, Mycobacterium colombiense, Mycobacterium arosiense, Mycobacterium vulneris, Mycobacterium bouchedurhonense, Mycobacterium timonense, Mycobacterium marseillense, Mycobacterium yongonense, Mycobacterium paraintracellulare and Mycobacterium lepraemurium.

Entities:  

Keywords:  Mycobacterium; Mycobacterium avium; Mycobacterium avium complex; clinical trials; phylogeny; taxonomy

Mesh:

Substances:

Year:  2018        PMID: 30231956     DOI: 10.1099/ijsem.0.003026

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  21 in total

1.  ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?

Authors:  Charles L Daley; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

2.  Granulomatous Rhinitis in a Horse due to Mycobacterium intracellulare Infection.

Authors:  K J Vail; L W Stranahan; L M Richardson; A E Yanchik; C E Arnold; B F Porter; D J Wiener
Journal:  J Comp Pathol       Date:  2019-05-14       Impact factor: 1.311

3.  GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Authors:  Hee Jae Huh; Su-Young Kim; Hyang Jin Shim; Dae Hun Kim; In Young Yoo; On-Kyun Kang; Chang-Seok Ki; So Youn Shin; Byung Woo Jhun; Sung Jae Shin; Charles L Daley; Won-Jung Koh; Nam Yong Lee
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

4.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

5.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

6.  Mycobacterium avium: an Emerging Pathogen for Dog Breeds with Hereditary Immunodeficiencies.

Authors:  Giovanni Ghielmetti; Urs Giger
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-18

7.  Disseminated Mycobacterium chimaera Following Open-Heart Surgery, the Heater-Cooler Unit Worldwide Outbreak: Case Report and Minireview.

Authors:  Emmanuel Lecorche; Gauthier Pean de Ponfilly; Faiza Mougari; Hanaa Benmansour; Elodie Poisnel; Frederic Janvier; Emmanuelle Cambau
Journal:  Front Med (Lausanne)       Date:  2020-06-16

8.  Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.

Authors:  Sanu Rajendraprasad; Christopher Destache; David Quimby
Journal:  Infect Dis Rep       Date:  2021-05-24

Review 9.  Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.

Authors:  Laura Rindi
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

10.  Mycobacterium chimaera Genomics With Regard to Epidemiological and Clinical Investigations Conducted for an Open Chest Postsurgical Mycobacterium chimaera Infection Outbreak.

Authors:  Emmanuel Lecorche; Côme Daniau; Kevin La; Faiza Mougari; Hanaa Benmansour; Sylvain Kumanski; Jérôme Robert; Sandra Fournier; Guillaume Lebreton; Anne Carbonne; Emmanuelle Cambau
Journal:  Open Forum Infect Dis       Date:  2021-04-16       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.